BioNTech Phase 3 trial of variant-adapted BNT162b2 COVID vaccine recruitingSep 30Weekly roundup, 7 itemsatirmociclibberobenatide
Roche posts IMpower010 results in resected NSCLC; adds polatuzumab real-world studySep 30Weekly roundup, 9 itemsafimkibartatezolizumabUpdated
Pfizer recalls dopamine injection lot; two Phase 3 trials remain not yet recruitingSep 24Weekly roundup, 4 itemsdopaminePfizer
Pfizer wins Xeljanz label update; registers four new trials across RSV, eczema, sleep apneaSep 16Weekly roundup, 7 itemsabrocitinibberobenatide
Pfizer-linked studies registered: rimegepant chemo trial, HIBA respiratory virus reviewSep 11Weekly roundup, 2 itemsPfizerrimegepant
Medicus Pharma subsidiary signs co-development deal with Pfizer for antibody-drug conjugateSep 3PartnershipMedicus Pharma Ltd.Pfizer
CIBINQO label updated by FDA; Pfizer's rimegepant China trial and pipeline items still activeSep 3Weekly roundup, 7 itemsabrocitinibberobenatide
Pfizer posts MET097 obesity results; registers new Phase 3 obesity and dermatitis trialsAug 28Weekly roundup, 6 itemsberobenatidePF-08154225
FDA approves updated Pfizer-BioNTech COVID-19 vaccine targeting XFG variantAug 27Regulatory decisionBioNTech SEPfizer
FDA approves ZAVZPRET label update; Pfizer registers RSVpreF and prostate cancer studiesAug 21Weekly roundup, 7 itemsBioNTech SEPenbraya
EMA validates MAA for Pfizer and Valneva's Lyme disease vaccine candidateAug 14Regulatory decisionPfizerValneva SE
Pfizer posts hemophilia results, opens eczema Phase 3, ends two skin studies earlyAug 14Weekly roundup, 6 itemsmarstacimab-hncqPF-06823859
Arbutus reaches FDA alignment on imdusiran Phase 2b design, advances Pfizer/BioNTech LNP suitsAug 12Quarterly updateArbutus Biopharma CorpPfizer
Pfizer registers Phase 3 trials in alopecia areata and chronic migraine; two Phase 1 studies openJul 29Weekly roundup, 5 itemsBioNTech SEPF-08642534
Pfizer week: AML donor-leukocyte trial posts results; three early trials advanceJul 24Weekly roundup, 4 itemsgemtuzumab ozogamicinPF-08653945
Arbutus terminates RSV side deal with Genevant, discloses CEO and CFO Moderna bonusesJul 16PeopleArbutus Biopharma CorpPfizer
Pfizer wins four Zithromax label updates in one week; two Phase 2 trial results also postedJul 15Weekly roundup, 6 itemsatirmociclibazithromycin
Pfizer recruiting Phase 4 rimegepant safety study in India for triptan-refractory migraine patientsJul 6Trial updatePfizerrimegepant
Pfizer wins five FDA label updates for tofacitinib, ritlecitinib, abrocitinib; Crohn's trial haltedJul 2Weekly roundup, 12 itemsabrocitinibatirmociclib
Sign in